A1M Pharma has successfully conducted large scale manufacturing of the active substance in ROSGard™ and initiates GLP toxicology studies
A1M Pharma's manufacturing partner has successfully and completely within the set time frame manufactured the first large scale batch of the active substance in the candidate drug ROSGard™. After conducted tests that verified good quality and a high level of purity, A1M Pharma has decided to use this batch in the upcoming GLP toxicology studies.During 2016, A1M Pharma has performed an up-scaling of the manufacturing process for the active substance in the company's candidate drug ROSGard™, together with a leading European manufacturer. During 2016, the first large scale manufacturing of a